The major thing wrong with this company is the price is U3O8. Every effort is being made by the industry to rectify that, if they succeed we’ll see things turn around here. B22.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game